Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 9/20 | 0.41 |
| ▸ | CA1 | P00915 | 9/20 | 0.41 |
| ▸ | CA2 | P00918 | 9/20 | 0.41 |
| ▸ | CA4 | P22748 | 9/20 | 0.41 |
| ▸ | CA9 | Q16790 | 9/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12948844 | 0.91 | PTGDR2 (0.47) | PTPN1PTGDR2CA12CA1CA2 | |
| SCHEMBL989095 | 0.89 | PTPN1 (0.44) | PTPN1PTGDR2CA12CA1CA2 | |
| SCHEMBL990116 | 0.88 | PTPN1 (0.43) | PTPN1PTGDR2CA12CA1CA2 | |
| SCHEMBL13160853 | 0.88 | PTGDR2 (0.43) | PTPN1PTGDR2CA12CA1CA2 | |
| SCHEMBL12948911 | 0.84 | PTGDR2 (0.41) | PTPN1PTGDR2CA12CA1CA2 | |
| SCHEMBL13160869 | 0.82 | PTGDR2 (0.44) | PTPN1PTGDR2 | |
| SCHEMBL12948846 | 0.82 | CA12 (0.48) | PTPN1PTGDR2CA12CA1CA2 | |
| SCHEMBL12948913 | 0.81 | PTGDR2 (0.44) | PTPN1PTGDR2CA12CA1CA2 | |
| SCHEMBL2772335 | 0.81 | PTGDR2 (0.47) | PTPN1PTGDR2 | |
| SCHEMBL12948910 | 0.81 | PTGDR2 (0.44) | PTPN1PTGDR2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011002814-A2 | BIARYL OXYACETIC ACID COMPOUNDS | LIGAND PHARMACEUTICALS INC. (US) | 2011-01-06 | — | — | WO | disclosed |